Tigecycline generics are often priced competitively compared to other antibiotics. According to Drug Patent Watch, the availability of generic tigecycline can lead to cost savings for patients and healthcare systems. This can be particularly beneficial when considering the potential cost-effectiveness of using generics in place of brand-name medications [1]. The study published in the National Center for Biotechnology Information (NCBI) also emphasizes the importance of generic antibiotics in reducing healthcare costs while maintaining treatment efficacy [2]. Public Health Ontario further supports this notion by providing examples of how generic antibiotics can be cost-effective alternatives in antimicrobial stewardship programs [3].

Overall, the sources suggest that tigecycline generics can offer a cost-effective option compared to other antibiotics, which is important for healthcare systems aiming to optimize their resources while providing effective treatment.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/TIGECYCLINE
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575121/
[3] https://www.publichealthontario.ca/-/media/documents/A/2017/asp-metrics-examples.pdf